2nd International Conference on Pharmacology & Gene Therapy for Tinnitus 2 October 2025 (UK-based virtual event)

Submit your abstract for presentation in the 2^nd International Conference on Pharmacology & Gene Therapy for Tinnitus which is planned for 2^nd of October 2025. We invite you to submit your abstract on topics related to pharmaceutical or gene therapy interventions for tinnitus and hyperacusis by Tuesday 10^th June 2025.

The aim of this conference is to bring together researchers and clinicians from the fields of hearing science, pharmacology, and gene therapy to share their perspectives and scientific discoveries that can guide future development of tinnitus treatments. For information about the first conference click here.

Target audience: Healthcare professionals and members of public are welcome to attend.

KEY TOPICS:

• How to guide future developments in pharmacology and gene therapy for tinnitus by exploring:
• Mechanics of the cochlea
• Cochlear synaptopathy
• Structural & functional brain abnormalities
• Psychoacoustic and audiological characteristics of tinnitus
• Psychiatric mechanism of tinnitus distress
• Similarities and differences between dreams, hallucinations, unexplained sensory experiences, and tinnitus
• How to assess the effectiveness of future pharmacological interventions and gene therapy for tinnitus?
• What side effects for future drugs or gene therapy for tinnitus can be predicted?
• The legislations for gene therapy and its implications for tinnitus treatment
• How to identify specific patient population who might benefit from a certain medication?
• Can food supplements help tinnitus or improve tinnitus management outcomes?
• Preventative treatments for tinnitus

Submit your abstract by Tuesday 10^th June 2025 via admin@hashirtinnitusclinic.com

Conference Updates:  

3 February 2025

In the first day of Tinnitus Awareness Week 2025, we are pleased to announce two confirmed topics that will be discussed in the 2^nd International Conference on Pharmacology & Gene Therapy for Tinnitus which is planned for 2^nd of October 2025. Professor Thanos Tzounopoulos, Endowed Professor of Auditory Physiology at University of Pittsburgh will talk about his research on Mechanisms and Treatment Development for Tinnitus. Dr Kelly N. Jahn, AuD, PhD from The University of Texas at Dallas, Department of Speech, Language, and Hearing will talk about Efficacy of Pharmacological Interventions for Pain Hyperacusis: Preliminary Insights from the Patient Perspective.

Registration

Standard registration fee: £120

To register, please complete and submit the form below. We will send you the details via email.